Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-06 · accession 0001946439-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-10 | 2026-03-06+ | ANIP | Davis Krista | SVP, Chief HR Off | S - Sale | $74.33 | -6,572 | 51.9K | -11% | -$488.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-06 | S | D | 1,485 | $75.00 | 57,033 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-09 | S | D | 5,087 | $74.13 | 51,946 | D | — | — | (F2) The shares were sold in multiple trades at prices ranging from $72.94 to $74.76. The price reported above reflects the weighted average sales price. |